Join us for the 5th International KAT6A & KAT6B Conference sponsored by the KAT6 Foundation!
June 8, 2024
890 Elkridge Landing Road, Linthicum Heights, MD, USA
The KAT6 Foundation’s annual conference aims to support individuals and their families living with KAT6A and KAT6B syndromes. With the goal to solidify KAT6A and KAT6B research internationally, this conference will also enable an open dialogue between families, clinicians and researchers.
Advance registration is mandatory.
This is a FREE event.
TARGETED PARTICIPANTS
Parents, caregivers, health care professionals, clinicians and researchers who are concerned with the care of individuals with KAT6 syndromes.
WHAT’S IN THIS YEAR’S CONFERENCE?
– Presentations by experts in KAT6A and KAT6B research fields
– Networking with the KAT6 Foundation
– Personal connections with KAT6 families, researchers and therapists
– Appointments with clinical geneticists, pediatric neurologists, and other health care professionals
– Social events with KAT6 families
PARTICIPATE IN RESEARCH
Studies on Cognition
Before clinical trials can be constructed to treat cognitive impairment in genetic diseases, scientists must first understand the cognitive phenotype of the disease in order to identify potential outcome measures, which has to be applicable across age and severity of cognitive impairment.
Participants ages 5-18 are needed for a new research study aimed to identify the unique cognitive profile of KAT6 disorders. The principal investigator is Dr. Rowena Ng from the Department of Neuropsychology at Kennedy Krieger Institute.
Learn More About the Cognitive Study
Participants under 5 years old needed for a research study that aims to examine early developmental profile and trajectory of KAT6 disorders. The principal investigator is Dr. Rowena Ng from the Department of Neuropsychology at Kennedy Krieger Institute.
Learn More About Baby/Toddler Study
They will draw blood for laboratory studies of cells. Blood samples will be used to identify disease-associated biomarkers for diagnosis and for future assessment of any new therapies. They will draw 3 vials of blood for this study. All ages may participate. Parents and siblings are encouraged to participate as controls samples for this study.
KAT6A and KAT6B patient-derived induced Pluripotent Stem Cell (iPSC) Bank: Capturing the Spectrum of KAT6 Pathogenic variants
The Serrano Lab at the Center for Regenerative Medicine (CReM) is working together with the KAT6 Foundation to establish the first KAT6A and KAT6B patient-derived iPSC bank. The CReM bank serves as a repository for sharing KAT6A and KAT6B human iPSC lines with internal and external investigators to conduct both basic and translational research.
JOIN US FOR SOME FUN!
We are thrilled to announce some exciting networking activities lined up alongside the cutting-edge research and science sessions at the conference. These activities are designed to foster connections and create memorable experiences for all attendees and their families.
